Summary A method for estimating both structural and functional vascular volumes in murine sarcomas is described. Intact vessels were demonstrated by the presence of laminin, a basement membrane-associated antigen, using an immunofluorescent technique. and functional vessels in the same sample by prior injection with the DNA binding dye Hoechst 33342. No significant vascular effects were seen after melphalan but a very pronounced decrease in both functional and structural vascular volume was seen after MISO. Combined chemotherapy of a murine sarcoma with melphalan and MISO induced a rapid decrease in the functional vascular volume, anid there was a resumption of blood flow prior to measurable regrowth. The fully regrown tumour retained the vascular characteristics of untreated tumours of similar size.
The observed effects of ionizing radiation on tumour growth are attributed by some authors to a direct cytotoxic action on tumour cells, as well as an indirect cytotoxic action, resulting from vascular and stromal damage (Thomlinson & Craddock, 1966; Mattson & Peterson, 1979) . Vascular damage may also represent an important component in the therapeutic effectiveness of hyperthermia, where the increased sensitivity of tumour vasculature to heat could lead to enhanced tumour cell kill (for review see Song, 1984) . As occlusion of the vasculature can alone lead to tumour control or cure (Denekamp et al., 1983) , the vascular component of any form of therapy must not be underestimated; indeed the vasculature itself may represent an important target for therapy (Denekamp, 1984) . In contrast to radiation and hyperthermia, however, little is known about the possible contribution of a vascular component in chemotherapy; in general the effects are considered the result of direct tumour cell kill.
In this study we have examined the effects of the alkylating agent melphalan on the vasculature of a murine sarcoma when used alone or in combination with the radiosensitizer Misonidazole (MISO) . MISO is known to potentiate the effects of melphalan. The origins of this phenomenon, known as 'chemosensitization', are not fully understood. Among the possible mechanisms that have been proposed are: that MISO is directly cytotoxic to hypoxic cells, alters the pharmacokinetics of the cytotoxic drugs, interferes with the repair of potentially lethal damage, or depletes intracellular thiols; (For reviews see McNally, 1982; Millar, 1982; Siemann, 1982; . The present study was carried out to determine whether a vascular component could be attributed to the potentiation of melphalan cytotoxicity by MISO. Although many methods exist for studying structural and functional parameters of normal tissues and tumours, in general these methods do not distinguish patent vessels from those which may be temporarily, or permanently, non functional. We utilize here a method whereby, in the same tumour sample, structural and functional information can be obtained using a morphometric technique. The method relies upon the identification of blood vessels by the immunolluorescent demonstration of the glycoprotein laminin, present in the blood vessel walls (Timpl et al., 1979) . This structural marker was used in parallel with a functional fluorescent marker, bis-benzamide Hoechst 33342, injected into the mouse prior to sacrifice. The actual structural vascular volume as well as the proportion of functional vessels could then be estimated. 
Materials and methods

Mice and tumours
All experiments were carried out on the sarcoma SA FA grown in WHT/Gy f BSVS mice. This tumour arose spontaneously at the Gray Laboratory and has been maintained by serial passage in the inbred strain of origin. The tumour is transplanted subcutaneously by trocar as 1 mm3 pieces on to the backs of mice. Histologically, the SA FA tumour is poorly differentiated and anaplastic, and metastasizes to the regional lymph nodes.
Drug treatments
Melphalan was first dissolved in 0.5ml of 2% HCI in ethanol and then further diluted with 9.5ml sterile saline, prior to administration. MISO was dissolved in sterile saline. Both drugs were administered simultaneously i.p. according to body weight of each animal; melphalan at a dose of I0 mg kg-1 and MISO at I,000 mg kg-1.
Tumnour nmeasurement and growtth delaY estimation Tumour-bearing mice were treated with melphalan, MISO or a combination of both when the geometric mean diameter (GMD) of the tumour was -7.5mm. Tumours were then measured in 3 orthogonal dimensions 2-3 times per week and GMDs calculated. The investigator was unaware of which treatment group was being measured. Tumour response after treatment was assessed as the additional time taken for the tumours to grow to 4 mm above treatment size.
Hoechst 33342 staining of tumour blood vessels At specific times after treatment, or when tumours had reached specified sizes, mice were injected i.v. via the tail vein with a solution of the fluorescent DNA-binding dye Hoechst 33342 in a volume of 300,uI of sterile saline. Mice were killed by cervical dislocation after injection and the tumour rapidly excised and frozen in liquid nitrogen and stored at -70°C. Preliminary experiments were carried out to determine both optimal dosage of Hoechst 33342 and optimal circulation time before sacrifice. A range of doses from 5-40mgkg-1 and circulation times from 1 to 30 min post injection were used.
Basement membrane staining of blood vessels
The basement membrane (BM) of blood vessels in tumours was visualised by the indirect immunofluorescence method, using a rabbit antiserum to mouse laminin. The glycoprotein laminin is a structural component of normal basement membranes including those of blood vessels of all sizes (Timpi et al., 1979; Barsky et al., 1983 (Chalkley, 1943) . In brief, a grid containing 25 randomly distributed spots was placed in the microscope eyepiece and the number of times a spot fell within a specified area, in this case within a vessel or on the vessel wall, was scored. Repetition of this procedure over a specified number of randomly chosen fields in the tumour section will in theory give a figure closely approximating to the proportion of total volume occupied by these structures. All estimates were based upon the counting of a minimum of 40 fields randomly chosen from 2 sections, one from the midline of the tumour and one halfway between the distal edge and the midline. In the case of Hoechst staining, only points falling within the central regions of the 'haloes' were included in the estimation. All sections were scored 'blind', each slide being labelled only with a mouse code number.
Most estimates of Hoechst and BM vascular volume were based upon pooled data from 2 separate experiments. In the case of early time points the means were based upon pooled data from three experiments.
Results
Ef,cct of nelphalaan andS MISO oni tunmour grow th Melphalan alone caused a growth delay of -3 days, whereas the combination of melphalan and MISO caused a delay of -12 days. MISO alone had no effect on the growth of the tumour. (Figure 3a) .
Although there was a marked drop in BM vascular volume within 6 days of treatment, this was not reflected in the Hoechst vascular volume estimates which showed little deviation from control values (Figure 3b ).
Effect of MISO alone on vascular volume Figure 4a shows the growth curve for tumours treated with MISO alone. MISO treatment produced no significant growth delay.
The BM vascular volume of tumours dropped rapidly within 2 days of treatment, and remained below control values throughout the period of growth. The Hoechst vascular volume also fell rapidly, but recovered by day 4 and by the time tumours had reached approximately 12mm GMD was essentially identical to controls (Figure 4b function in the same sample. Assumptions about changes in vascular structure are frequently based upon induced functional changes and vice versa. The use of contrast media, such as India ink (Lewis, 1927) and colloidal carbon (Hilmas & Gillette, 1973) , or radio-opaque medium (Solesvik et al., 1984; Margulis et al., 1961) , although providing elegant structural information about tumour vasculature, must necessarily neglect those vessels which may not be available to the contrast agent at the time of the experiment. Conversely those methods which aim to determine vascular volume, and other parameters, by purely histochemical means (Tannock & Steel, 1969; Revesz & Siracka, 1984) provide little information about the efJective functional vascular volume. To some extent the method we have described in this paper overcomes these problems, providing not only information about the total volume of tumour occupied by the vasculature, but also the fraction of vessels which were functional within a minute of sacrifice. Hoechst 33342 has proven a useful tool for outlining vascular structures in tumours (Rheinhold & Visser, 1983) , for cell selection based upon distance from blood vessels (Durand, 1982; Chaplin et al., 1985) , and for estimation of vascular volume (Smith et al., 1986 ). The dye is rapidly taken up by endothelial cells (Rheinhold & Visser, 1983) , as well as tumour cells (Rheinhold & Visser, 1983; . However, diffusion is limited to within a few cell layers of the blood vessels, for at least the first few hours after injection . In our experiments, a one (Figure 1 b) , and subsequent measurements of vascular space were not significantly altered by longer exposure to the dye. This short exposure will naturally only highlight vessels where blood flow is relatively fast and fail to define vessels which have a stagnant flow. It is also likely that differences will exist between tumour models, particularly in view of their variable vascular characteristics, and therefore the precise conditions described here may only apply to the SA FA tumour.
The use of antibodies to BM markers represents perhaps the most sensitive means of detecting small blood vessels in normal and neoplastic tissues (Barsky et al., 1983) . In human sarcomas blood vessels of all sizes stain positively for laminin and collagen type IV when specific antibodies are used, whilst, in general other areas remain negative (Birembaut et al., 1985) . Antibodies to laminin will also distinguish blood vessel and lymphatic capillaries, as the latter lack laminin (Barsky et al., 1983) . Unfortunately, carcinomas frequently express laminin as a constitutive product, not necessarily related to vascular structures (Birembaut, 1985) , and therefore the technique we describe here can only readily be applied to sarcomas. In the case of the SA FA sarcoma good vessel definition was obtained (Figure la) .
In our experiments both indicators of vascular volume demonstrated a decrease as the control tumours grew, although only in the case of the Hoechst vascular volume was the change statistically significant (Figure 2) . Morphometric analyses by other authors have revealed similar changes in some tumours (Vaupel, 1974 (Vaupel, , 1977 Gullino, 1975) , whereas in other tumours vascular volume was seen to remain constant (Vogel, 1965) . This decrease in vascular volume with size has been attributed to a progressive failure of the neovascularization process, or a diminished quality of vasculature as the tumour expands. The nutritive potential of the blood may also be compromised in the long vessel loops needed to reach the centre of large tumours. Falk (1978) has pointed out that thin-walled vessels may collapse as the hydrostatic pressure increases in the growing tumour. It has also been suggested that the loss of effective vasculature may be due to the differential in proliferation rates of endothelial cells and neoplastic cells (Tannock, 1970; Hirst et al., 1982) . Thomlinson & Gray (1955) and Rubin & Casarett (1966a, b) stressed the implication of this phenomenon for radiotherapy, since a diminished vascular supply may lead to a hypoxic, radioresistant fraction. The apparent diminution in vascular volume with size may also be relevant to chemotherapy: Shipley et al. (1975) , and more recently Smith et al. (1985) , have suggested that the availability of chemotherapeutic agents may be diminished in large tumours, which may explain in part the observations of Steel & Adams (1975) (Figure 3) , despite a three day growth delay induced by the drug. MISO alone, on the other hand had a dramatic effect on both Hoechst and BM vascular volume estimates (Figure 4 ). This was an unexpected result and had not previously been recognised. Indeed, there is little information in the literature about possible vascular effects of this drug. By contrast, MISO has been shown to increase the vascular area in the subepithelium of the rabbit trachea (Albertsson et al., 1985) . Also, the decrease in heart rate, respiration rate and body temperature that have been observed in mice after high MISO doses (Gomer & Johnson, 1979; Chin & Rauth, 1981; Conroy et al., 1980) have been postulated as resulting from a systemic vascular effect (Conroy et al., 1980) . These effects are transient however, lasting only a few hours. The prolonged reduction in vascular space seen in the present study could initially be a passive response to a systemic vasodilation (a 'steal' effect), but that does not explain the duration of the effect. Other authors have speculated that vasodilators in general may cause a relative decrease in tumour blood flow (Ackerman, 1972; Wickersham et al., 1977) . However, we cannot rule out the possibility that MISO, or toxic metabolites of MISO are having a direct effect on the endothelial cells of the tumour vasculature.
The tumoricidal effects of MISO as a single agent have been attributed to its metabolism in hypoxic cells into a toxic product. This cytotoxic effect has been demonstrated in vitro by several groups (Hall & Roizin-Towle 1975; Stratford & Adams, 1977) and has led to a wider appreciation of the potential of bioreductive metabolism as an antitumour approach. The very extensive necrosis seen in the KHT tumour after high doses of MISO led Brown (1977) to postulate that the toxic metabolite could diffuse to, and kill, cells other than the hypoxic cells that had produced it. An alternative explanation of the extensive necrosis would be that it resulted from additional prolonged ischaemia as a result of a MISO-induced vascular shutdown.
The combination of MISO and melphalan induced an equally dramatic decrease in vascular volume estimates, but this decrease persisted longer than that for MISO alone ( Figure 5 ). If MISO administered simultaneously with melphalan reduces blood flow in the tumour, melphalan may remain in contact with both endothelial and tumour cells longer, resulting in increased cytotoxicity to both. Such a hypothesis is supported by the observation (Randhawa et al., 1985 ) that MISO at 1000mgkg-I significantly increases the half-life of melphalan in the SA FA tumour and plasma of WHT mice, and that maximum chemosensitization occurs when the drugs are administered simultaneously (Randhawa et al., unpublished) . As our first time points are at 24h after treatment, we are unable to say how rapid is the onset of this vascular effect. We are currently investigating this topic in more detail. The apparent reduction in vascular volume estimates using the BM stain indicate that vessels must actually collapse rather than simply becoming stagnant. If the vessels flatten they will appear less often in a morphometric analysis than dilated vessels. The possibility that the laminin has been resorbed, or is failing to stain, cannot be excluded, but this seems less likely than simple collapse. In the regrowing tumour (after day 14), BM vascular volume increased once more to a level similar to that observed in control tumours.
In Figure 6 we have chosen to express the data as ratios of Hoechst vascular volume to BM vascular volume. This plot emphasises the point that under most conditions only a fraction of the total available vascular space is functional. In the case of control SA FA tumours (Figure 6a ) this fraction was 50% falling slightly (but not significantly) to 40%. This was not an unexpected result: Using radio-isotope techniques, Tannock & Steel (1969) have demonstrated that there exists a certain proportion of blood in tumours which does not exchange with that of the general circulation. Stasis in these vessels may then be followed by thrombosis and vessel occlusion (Gullino, 1975; Vaupel, 1977) .
In melphalan-treated tumours the ratio of Hoechst vascular volume to BM vascular volume followed a similar pattern to that of controls (Figure 6b) . After MISO or combined treatment the ratios diminished dramatically (Figure 6c, d) indicating that the efJective fraction of the vascular space (as well as the total detectable volume) was reduced as a result of treatment. At the time of regrowth of the tumours treated with MISO and melphalan, the ratio showed a small peak of perfusion (Figure 6d ), although this peak was not significantly different from control tumours of the same size. It appears from our experiments with MISO alone that a significant loss of vascular function can be demonstrated without any measurable effect on growth rate. Conversely, melphalan alone induces a small but significant growth delay, without affecting the vascular volume of the tumour. We conclude that the loss of effective vascular volume in the combined therapy is not necessarily the primary cause of measurable growth delay, and that the net effect may be the result of a combination of some direct cell kill, coupled with further cell death due to vascular insufficiency.
The extent to which vascular effects of MISO can account for chemosensitization by alkylating agents, the apparent MISO-induced necrosis seen in some tumours (Brown, 1977) , or even the enhanced sensitivity of some normal tissues has yet to be investigated. It is clear, however, that the influence of MISO may be indirectly mediated via a physiological response and cannot now be assumed to be a simple local chemical action within individual hypoxic cells.
